Longitudinal changes in serum adropin levels and liver fat content during liraglutide treatment in newly diagnosed patients with type 2 diabetes mellitus and metabolic dysfunction-associated fatty liver disease

AIMS: To explore the effect of liraglutide treatment on serum adropin and its relationship to the liver fat content in newly diagnosed patients with type 2 diabetes mellitus (T2DM) and metabolic dysfunction-associated fatty liver disease (MAFLD). METHODS: Serum adropin level and liver fat content we...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Lin, Wu, Xiaojuan, Li, Xinyue, Chang, Xiaona, Ding, Xiaoyu, Wang, Qiu, Jiang, Tao, Wang, Guang, Liu, Jia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10198855/
https://www.ncbi.nlm.nih.gov/pubmed/37079136
http://dx.doi.org/10.1007/s00592-023-02082-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10198855/
https://www.ncbi.nlm.nih.gov/pubmed/37079136
http://dx.doi.org/10.1007/s00592-023-02082-3

Ejemplares similares